Goldman Sachs Portfolio holdings
Goldman Sachs, founded in 1869 by Marcus Goldman and later joined by Samuel Sachs, is a premier global investment bank headquartered in New York City, renowned for its influential role in financial markets. The firm provides a wide range of services, including investment banking (mergers, acquisitions, and underwriting), securities trading, asset management, and consumer banking through its Marcus platform, catering to corporations, governments, institutions, and high-net-worth individuals. Known for its elite status on Wall Street, Goldman Sachs has a history of navigating major economic events, from the Great Depression to the 2008 financial crisis, where it played a controversial yet pivotal role. With a strong emphasis on innovation and a global footprint, it manages billions in assets and remains a powerhouse in shaping economic policy and market trends.
Top Buys
| 1 |
Invesco QQQ Trust
QQQ
|
$2.8B |
| 2 |
Alibaba
BABA
|
$1.34B |
| 3 |
Tesla
TSLA
|
$791M |
| 4 |
VAR
Varian Medical Systems, Inc.
VAR
|
$586M |
| 5 |
Itaú Unibanco
ITUB
|
$398M |
Top Sells
| 1 |
SPDR S&P 500 ETF Trust
SPY
|
$4.01B |
| 2 |
Apple
AAPL
|
$2.09B |
| 3 |
Visa
V
|
$1.65B |
| 4 |
Amazon
AMZN
|
$1.44B |
| 5 |
iShares Russell 2000 ETF
IWM
|
$1.26B |
Sector Composition
| 1 | Technology | 17.72% |
| 2 | Consumer Discretionary | 11.99% |
| 3 | Healthcare | 9.74% |
| 4 | Financials | 8.93% |
| 5 | Communication Services | 6.62% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
3976
Gorman-Rupp
GRC
$1.14B
| $205K | ﹤0.01% |
6,975
-3,016
| -30% | -$88.6K |
|
3977
Hercules Capital
HTGC
$3.49B
| $205K | ﹤0.01% |
17,692
-201,773
| -92% | -$2.34M |
|
3978
Artesian Resources
ARTNA
$343M
| $203K | ﹤0.01% |
5,887
-2,113
| -26% | -$72.9K |
|
|
HIO
3979
Western Asset High Income Opportunity Fund
HIO
$375M
| $203K | ﹤0.01% |
41,375
+5,300
| +15% | +$26K |
|
3980
Hyster-Yale Materials Handling
HY
$668M
| $203K | ﹤0.01% |
5,462
-29,560
| -84% | -$1.1M |
|
3981
Lexicon Pharmaceuticals
LXRX
$396M
| $203K | ﹤0.01% |
141,495
-374,647
| -73% | -$537K |
|
|
UBX
3982
DELISTED
Unity Biotechnology
UBX
| $203K | ﹤0.01% |
5,858
-375
| -6% | -$13K |
|
3983
Eastern Company
EML
$146M
| $202K | ﹤0.01% |
+10,331
| New | +$202K |
|
3984
Neuronetics
STIM
$214M
| $202K | ﹤0.01% |
41,577
-1
| -0% | -$5 |
|
|
CHMI
3985
Cherry Hill Mortgage Investment Corp
CHMI
$105M
| $199K | ﹤0.01% |
22,136
-11,130
| -33% | -$100K |
|
3986
Corbus Pharmaceuticals
CRBP
$121M
| $199K | ﹤0.01% |
3,695
+1,395
| +61% | +$75.1K |
|
|
EMO
3987
ClearBridge Energy Midstream Opportunity Fund
EMO
$864M
| $199K | ﹤0.01% |
22,656
-23,400
| -51% | -$206K |
|
3988
Blue Owl Capital
OBDC
$7.33B
| $199K | ﹤0.01% |
+16,528
| New | +$199K |
|
|
REV
3989
DELISTED
Revlon, Inc.
REV
| $199K | ﹤0.01% |
+31,487
| New | +$199K |
|
3990
Emerald Holding
EEX
$1.02B
| $198K | ﹤0.01% |
97,284
+1,892
| +2% | +$3.85K |
|
|
GRTS
3991
DELISTED
Gritstone bio, Inc. Common Stock
GRTS
| $198K | ﹤0.01% |
74,942
+36,635
| +96% | +$96.8K |
|
|
HECCU
3992
DELISTED
Hudson Executive Investment Corp. Units
HECCU
| $196K | ﹤0.01% |
18,937
| – | – |
|
3993
Graham Corp
GHM
$524M
| $194K | ﹤0.01% |
15,177
-3,091
| -17% | -$39.5K |
|
3994
Pixelworks
PXLW
$46.2M
| $194K | ﹤0.01% |
7,868
-10,484
| -57% | -$259K |
|
|
ZYNE
3995
DELISTED
Zynerba Pharmaceuticals, Inc
ZYNE
| $193K | ﹤0.01% |
58,260
-1,531
| -3% | -$5.07K |
|
3996
AC Immune
ACIU
$229M
| $192K | ﹤0.01% |
39,321
-19,271
| -33% | -$94.1K |
|
|
CRON
3997
Cronos Group
CRON
$957M
| $192K | ﹤0.01% |
38,380
-66,446
| -63% | -$332K |
|
3998
Passage Bio
PASG
$22.8M
| $192K | ﹤0.01% |
+734
| New | +$192K |
|
|
THCA
3999
DELISTED
Tuscan Holdings Corp. II Common Stock
THCA
| $192K | ﹤0.01% |
19,200
-249,800
| -93% | -$2.5M |
|
4000
Adecoagro
AGRO
$829M
| $191K | ﹤0.01% |
40,939
-12,015
| -23% | -$56.1K |
|